"ETG NETWORK to sieć ośrodków, które umożliwiają Pacjentom dostęp do bezpłatnego, innowacyjnego leczenia w ramach badań klinicznych. Ośrodek KUBA-MED przy ul. Kunickiego 26a w Lublinie."

During the past decade, ETG Łódź conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 1 clinical trials were completed, i.e. on average, 12.5% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 1 clinical trials were completed. i.e. 20% of trials that started reached the finish line.

Out of the total clinical trials conducted in "ETG Łódź" #1 sponsor was "Concert Pharmaceuticals" with 2 trials, followed by "Galapagos NV" with 1 trials sponsored, "IBSA Institut Biochimique SA" with 1 trials sponsored, "Otonomy, Inc." with 1 trials sponsored and "Regeneron Pharmaceuticals" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "ETG Łódź" #1 collaborator was "Iqvia Pty Ltd" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "ETG Łódź" are "Alopecia Areata" (2 trials), "Agitation" (1 trials), "Allergic Rhinitis Due to Cat Allergy" (1 trials), "Alzheimer's Type Dementia" (1 trials) and "Atopic Dermatitis" (1 trials). Many other conditions were trialed in "ETG Łódź" in a lesser frequency.

Most popular intervention types in "ETG Łódź" are "Drug" (7 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "CTP-543" (1 trials), "CTP-543, 12 mg BID" (1 trials), "CTP-543, 8 mg BID" (1 trials) and "Ensifentrine" (1 trials). Other intervention names were less common.

The vast majority of trials in "ETG Łódź" are 8 trials for "All" genders.

Currently, there are NaN active trials in "ETG Łódź". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in ETG Łódź, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in ETG Łódź, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".